Currently, the medication is unavailable outside of clinical trials . Accessing it requires enrollment in a designated research trial, which is generally conducted at leading medical facilities . https://glp-3-retatrutide-for-sa728932.csublogs.com/50065537/accessing-retatrutide-access-where-to-get-a-glp-3-agonist-treatment